# Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke

> **NCT07095790** · PHASE4 · RECRUITING · sponsor: **Second Affiliated Hospital of Soochow University** · enrollment: 580 (estimated)

## Conditions studied

- Mild Stroke

## Interventions

- **DRUG:** Tirofiban+Oral Dual Antiplatelet Therapy
- **DRUG:** Oral Dual Antiplatelet Therapy

## Key facts

- **NCT ID:** NCT07095790
- **Lead sponsor:** Second Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-30
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-05-31
- **Target enrollment:** 580 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07095790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07095790, "Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07095790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*